DB19014InvestigationalGene Therapies
Imdusiran is under investigation in clinical trial NCT06245291 (Study of Imdusiran (AB-729) in Combination With Intermittent Dosing of Durvalumab in Subjects With Chronic HBV Infection).
- Code names
- AB-729 · AB-729 free acid
Resolves to
Compound
What you can answer from here — as of November 22, 2025
Which companies are running trials of Imdusiran, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account